Unpublished Tweets by Sam Bankman-Fried Offer Insights into His Mental Health

cryptonews.com:

A series of unpublished tweets belonging to FTX founder Sam Bankman-Fried have revealed insights into his mental health and prescribed medication. 

The unposted tweets, obtained by CoinDesk, indicate that Bankman-Fried has been discussing his mental health struggles, including mild depression and anhedonia, the inability to experience pleasure, since at least December.

"Things are a spectrum," Bankman-Fried wrote before his arrest last year on fraud and conspiracy charges. 

"I don’t have major depressive disorder, probably. But I do generally test positive for dysthymia [a form of mild, long-term depression], and anhedonia [the inability to feel pleasure]. My lows aren’t unusually low – but I generally don’t have highs."

Last week, the New York Times published highlights from 250 pages of similar draft tweets, which were leaked by social media personality and Bankman-Fried's confidante, Tiffany Fong. 

Bankman-Fried's tweets indicate that he first became aware of his mental health issues during high school, describing a lack of happiness and an inability to comprehend the concept. 

He revealed that he had been prescribed an antidepressant called EmSam for the past decade to help manage his mental well-being. 

Bankman-Fried was an advocate for EmSam and even hired a psychiatrist as a company coach, who allegedly liberally dispensed prescriptions to FTX employees, according to Department of Justice attorneys.

While in custody at the Metropolitan Detention Center in Brooklyn, Bankman-Fried's attorney raised concerns about his access to prescription drugs, claiming that he was not receiving his Adderall and was worried about running out of EmSam. 

Additionally, his vegan dietary restrictions were not considered, resulting in a limited